Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Total 13F shares
-
1,767,833
-
Share change
-
+266,750
-
Total reported value
-
$13,965,000
-
Price per share
-
$7.90
-
Number of holders
-
10
-
Value change
-
+$2,101,428
-
Number of buys
-
7
-
Number of sells
-
4
Institutional Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q2 2019
As of 30 Jun 2019,
Eton Pharmaceuticals, Inc. - Common Stock (ETON) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,767,833 shares.
The largest 10 holders included
Opaleye Management Inc., AWM Investment Company, Inc., Diametric Capital, LP, PRELUDE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., WELLS FARGO & COMPANY/MN, Tower Research Capital LLC (TRC), MORGAN STANLEY, and UBS Group AG.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.